1
/
of
0
FDA Drug Approval, A216605, ROPIVACAINE HYDROCHLORIDE
FDA Drug Approval, A216605, ROPIVACAINE HYDROCHLORIDE
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
ANDA: 216605
Company: AMNEAL
Drug Name: ROPIVACAINE HYDROCHLORIDE
Active Ingredients: ROPIVACAINE HYDROCHLORIDE
Strength: 1GM/200ML (5MG/ML)
Dosage Form/Route: SOLUTION;INJECTION
Action Date: 03/08/2023
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AP
Company: AMNEAL
Drug Name: ROPIVACAINE HYDROCHLORIDE
Active Ingredients: ROPIVACAINE HYDROCHLORIDE
Strength: 1GM/200ML (5MG/ML)
Dosage Form/Route: SOLUTION;INJECTION
Action Date: 03/08/2023
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AP
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details